Corteva annual total liabilities
2018
2019
2020
2021
2022
2023
2024
2025
Corteva Total Liabilities Growth & History (CTVA)
Corteva's total liabilities was $18.46B for fiscal 2025.
View full Corteva company overviewCorteva annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $18.46B | $1.66B | +9.91% |
| 2024 | 2024-12-31 | $16.80B | −$922.0M | −5.20% |
| 2023 | 2023-12-31 | $17.72B | $640.0M | +3.75% |
| 2022 | 2022-12-31 | $17.08B | $356.0M | +2.13% |
| 2021 | 2021-12-31 | $16.72B | −$865.0M | −4.92% |
| 2020 | 2020-12-31 | $17.59B | −$256.0M | −1.43% |
| 2019 | 2019-12-31 | $17.84B | −$15.69B | −46.79% |
| 2018 | 2018-12-31 | $33.53B | — | — |
Corteva quarterly total liabilities
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $16.24B | $631.0M | +4.04% |
| Q1 2026 | 2026-03-31 | $18.11B | $516.0M | +2.93% |
| Q4 2025 | 2025-12-31 | $18.46B | $1.66B | +9.91% |
| Q3 2025 | 2025-09-30 | $16.74B | −$192.0M | −1.13% |
| Q2 2025 | 2025-06-30 | $15.61B | −$435.0M | −2.71% |
| Q1 2025 | 2025-03-31 | $17.60B | −$1.02B | −5.48% |
| Q4 2024 | 2024-12-31 | $16.80B | −$922.0M | −5.20% |
| Q3 2024 | 2024-09-30 | $16.93B | −$714.0M | −4.05% |
| Q2 2024 | 2024-06-30 | $16.04B | −$1.69B | −9.50% |
| Q1 2024 | 2024-03-31 | $18.62B | −$1.04B | −5.31% |
| Q4 2023 | 2023-12-31 | $17.72B | $640.0M | +3.75% |
| Q3 2023 | 2023-09-30 | $17.64B | $2.08B | +13.34% |
| Q2 2023 | 2023-06-30 | $17.73B | $2.89B | +19.50% |
| Q1 2023 | 2023-03-31 | $19.66B | $2.96B | +17.75% |
| Q4 2022 | 2022-12-31 | $17.08B | $356.0M | +2.13% |
| Q3 2022 | 2022-09-30 | $15.57B | −$576.0M | −3.57% |
| Q2 2022 | 2022-06-30 | $14.84B | −$1.04B | −6.53% |
| Q1 2022 | 2022-03-31 | $16.70B | −$1.07B | −6.04% |
| Q4 2021 | 2021-12-31 | $16.72B | −$865.0M | −4.92% |
| Q3 2021 | 2021-09-30 | $16.14B | −$1.20B | −6.92% |
| Q2 2021 | 2021-06-30 | $15.87B | −$1.51B | −8.68% |
| Q1 2021 | 2021-03-31 | $17.77B | −$1.13B | −5.97% |
| Q4 2020 | 2020-12-31 | $17.59B | −$256.0M | −1.43% |
| Q3 2020 | 2020-09-30 | $17.34B | −$630.0M | −3.51% |
| Q2 2020 | 2020-06-30 | $17.38B | −$476.0M | −2.67% |
| Q1 2020 | 2020-03-31 | $18.90B | −$16.13B | −46.05% |
| Q4 2019 | 2019-12-31 | $17.84B | −$15.69B | −46.79% |
| Q3 2019 | 2019-09-30 | $17.97B | — | — |
| Q2 2019 | 2019-06-30 | $17.86B | — | — |
| Q1 2019 | 2019-03-31 | $35.03B | — | — |
| Q4 2018 | 2018-12-31 | $33.53B | — | — |
Corteva total liabilities trends
Over the last five fiscal years, Corteva's total liabilities increased from $17.59B to $18.46B, a change of $873.0M. The latest reported quarter, Q2 2026, shows $16.24B.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Corteva source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...